The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice?

Scand J Gastroenterol. 1995 May;30(5):401-7. doi: 10.3109/00365529509093298.
No abstract available

Publication types

  • Review

MeSH terms

  • Amoxicillin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Bismuth / therapeutic use
  • Clarithromycin / therapeutic use
  • Clinical Trials as Topic
  • Drug Resistance, Microbial
  • Drug Therapy, Combination
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori* / drug effects
  • Humans
  • Metronidazole / therapeutic use
  • Omeprazole / therapeutic use
  • Organometallic Compounds / therapeutic use
  • Randomized Controlled Trials as Topic
  • Tetracycline / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Organometallic Compounds
  • Metronidazole
  • Amoxicillin
  • Tetracycline
  • Clarithromycin
  • bismuth tripotassium dicitrate
  • Omeprazole
  • Bismuth